Research Use Only. For Laboratory Research Only. Not for Human or Veterinary Consumption. Not evaluated by the FDA.
Independently verified · >99% HPLC purity · Batch-level COAs

Advancing scientific research through premium biotechnology.

High-purity laboratory research compounds supported by independent testing, transparent documentation, and scientific integrity.

Independently assayed
Chain-of-custody documentation
Batch-level traceability
HPLC Purity
99.4%
Batch
BX-2941
LC-MS
✓ Confirmed

Trusted by research teams at

Meridian Bio
Helix Labs
Northwind Research
Axiom Therapeutics
Cellera
Vantage Genomics
Quality Metrics

The standards behind every vial.

99%+ Purity
HPLC verified
Third-Party Tested
Independent labs
Cold Chain Packaging
Temperature stable
Fast USA Shipping
24-hour dispatch
Research Use Only
In-vitro grade
The science stack

Built to pharmaceutical standards.

Every peptide passes through a documented, auditable pipeline — from raw amino acid to sealed vial — engineered for reproducible research.

Solid-phase synthesis

Fmoc-based SPPS in controlled cleanroom environments with in-process analytical checkpoints at every coupling stage.

HPLC + Mass Spec verified

Every batch is characterized by reverse-phase HPLC and ESI-MS. Purity thresholds exceed 99% for research applications.

Third-party assay

Independent analytical laboratories cross-verify identity, potency, and endotoxin levels before release.

Cold-chain logistics

Insulated, temperature-monitored shipping preserves peptide stability from lyophilization to lab bench.

Full documentation

Batch-level certificates of analysis, HPLC chromatograms, and mass spectra delivered with every shipment.

Research-grade only

Compounds are supplied strictly for in-vitro laboratory investigation under qualified institutional oversight.

99.4%
Average HPLC purity
<0.05
EU/mg endotoxin ceiling
Independent verifications
24h
COA delivery window
Quality architecture

A quality system engineered
the way biotech does it.

Our processes borrow from GMP pharmaceutical manufacturing — not from the supplement industry. Every step is documented, every deviation is investigated, every batch is defensible.

  • USP <1225> compliant validation methodology
  • Cleanroom synthesis with continuous particulate monitoring
  • Sequence confirmation by high-resolution mass spectrometry
  • Residual solvent screening via headspace GC
  • Bioburden and endotoxin screening on every lot
  • Immutable digital chain-of-custody records
Customer Trust

Why researchers choose BioNex.

A partnership built on scientific rigor, quality control, and complete transparency.

Industry-leading quality

Every batch synthesized under cleanroom conditions and validated against pharmaceutical-grade release criteria.

Independent testing

Third-party analytical laboratories verify purity, identity, and endotoxin thresholds before shipment.

Transparent sourcing

Traceable supply chain from raw amino acids to sealed vial — every step is documented and auditable.

Scientific integrity

Strictly research-use compounds supplied to qualified institutions with honest, evidence-based communication.

Latest Research

Publications & field notes.

Publication
March 12, 2026

Comparative HPLC characterization of therapeutic GLP-1 analogs

A methods paper describing reproducible purity assessment across a panel of six research-grade peptides.

Whitepaper
February 28, 2026

Endotoxin control in solid-phase peptide synthesis

How cleanroom design, resin selection, and lyophilization protocols influence bioburden outcomes.

Article
February 5, 2026

Cold-chain logistics: preserving peptide integrity in transit

Empirical stability data across 72-hour temperature-monitored shipments to institutional laboratories.

Scientific briefings

Get new publications and product releases in your inbox.

One concise monthly briefing — methods, data, and catalog updates. No marketing noise.